Compare Plug Power Inc (PLUG) vs TG Therapeutics Inc (TGTX) Price & Performance

Plug Power (PLUG) trades at $2.26, up 4.15% today, but remains in a challenging fundamental position with persistent losses. The company shows modest revenue recovery to $710 million in 2025 but continues to report negative gross margins and substantial net losses. Technical indicators suggest a bullish short-term trend, while analyst sentiment remains divided with a $4.04 consensus price target representing significant upside potential from current levels.

While PLUG offers substantial upside based on analyst targets and growing electrolyzer demand, the investment carries high risk due to ongoing operational losses, negative cash flow, and heavy reliance on financing. The company's turnaround strategy shows early progress but requires sustained execution to achieve profitability amid competitive pressures in the hydrogen sector.

TG Therapeutics (TGTX) trades at $55.74, down 0.44% on the day, with a bullish technical signal from moving averages and a consensus analyst price target of $64.00. The company reported strong revenue growth, with Q2 2026 revenue reaching $240 million and full-year 2026 guidance raised to approximately $950 million, though recent quarterly EPS results have missed expectations. News highlights include conference participation and institutional buying interest, supporting positive sentiment.

The outlook remains optimistic driven by Briumvi's commercial growth and pipeline catalysts, but risks include earnings volatility, competitive pressures, and reliance on a key product. Upside potential exists if execution meets raised guidance, making it a focus for growth-oriented investors despite near-term profit misses.